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BACKGROUND: The presence of parametrial invasion in early stage squamous cell cervical cancer (SCCC) indeed indicates worse prognosis 
and need more adjuvant treatment. This study aimed to 
investigate the association between parametrial invasion 
and clinicohystopathology variables. 
METHODS: This retrospective study used specimens 
of squamous cell carcinoma stage IB-IIA. The inclusion 
criteria were cervical cancer stage IB-IIA and post radical 
hysterectomy with lymph node dissection and exclusion 
criteria was damaged and or insufficient histological 
preparations. The clinicohystopathology variables 
included age, tumour size and stage, differentiation and 
inflammation grade, lymphatic vascular and parametrial 
invasion, and lymph node metastasis. Histopathology 
staining, immunohistochemistry examination, and vascular 
endothelial growth factor-C (VEGF-C) expression were 
evaluated according to the standard procedure. The 
independent-T, Chi square, and Fisher’s exact test were 
applied to evaluate the  association. The significance was 
set at p<0.05. 
RESULTS: Seventy-five cases were eligible. Parametrial 
invasion was found in 15 cases (20%). Three variables 
demonstrated a significant association with parametrial 
invasion, tumor size >4 cm (OR 4.32, 95% CI 1.29-14.38, 
p=0.01), lymphatic node metastasis (OR 3.90, 95% CI 
1.17-13.03, p=0.02), and VEGF-C (OR 0.75, 95% CI 0.65-
0.87, p=0.03).
CONCLUSION: Tumor size of >4 cm and lymph node 
metastasis (LNM) had a higher risk of parametrial invasion 
in SCCC stage IB-IIA. 
KEYWORDS: cervical carcinoma, parametrial invasion, 
vascular invasion, peritumoral stroma, VEGF-C expression
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Abstract
Introduction
The high incidence and mortality of the cervical cancer 
occur in developing countries. Approximately 85% of the 
prevalence and 88% of the deaths due to cervical cancer 
are found in those countries.(1) Mortality of the cervical 
cancer is also high in Indonesia. There were an estimated 
9,498 deaths from cervical cancer annually, which was the 
second leading cause of death among Indonesian women.(2) 
The highest mortality was related to cancer progression and 
poor prognosis as indicated by tumor invasion and lymph 
node metastasis (LNM). Parametrial tissue is the most 
frequent site of tumor cells dissemination. The presence of 
parametrial invasion indicates worse prognosis and more 
radical surgery is needed in early stage cervical cancer.(3,4) 
 The vascular endothelial growth factor C (VEGF-C) 
is a member of vascular endothelial growth factor (VEGF) 
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family and has a role in angiogenesis. It is produced by 
tumor cells and peritumor.(5,6) The VEGF-C plays an 
essential role in lymphangiogenesis predominantly via 
vascular endothelial growth factor receptor-3 (VEGFR-3).
(7) By promoting new lymph vessels, the VEGF-C can 
accelerate tumor cells metastasis to lymph nodes and distant 
organs.(8) Prior studies reported that increased VEGF-C was 
correlated with poor prognosis in several types of cancers.
(9,10) A prior study reported that VEGF-C was proven to 
be involved in lympangiogenesis in cervical cancer and its 
gene expression increase according to the increase in the 
clinical stage.(11)  
 Lymphatic changes due to lymphangiogenesis 
intratumoral and peritumoral have been believed to cause 
distinct biological effect on tumor behaviour and prognosis. 
However, the results vary between studies. Study in gastric 
cancer revealed that the intratumoral lymphatic vessel 
density (LVD) was more associated with the presence 
of LNM in early stage whereas peritumoral LVD was an 
independent risk factor for LNM and prognosis.(12,13) 
Study on the expression of VEGF-C in peritumoral 
lymphatic has been performed. The results found increased 
expression of VEGF-C at the edge compared with the 
center of tumor were correlated with high peritumoral LVD, 
lymphovascular invasion (LVI), and nodal metastasis. These 
indicated that the peritumoral lympatic invasion was linked 
with tumor metastasis and expected to be an independent 
prognostic factor in cervical cancer.(14) On the contrary, 
study on gastric cancer reported that intratumoral, but not 
peritumoral, lymphatic vessel density (LVD) was closely 
related with LNM and poor prognosis.(15) 
 To the best of our knowledge, there may be fewer 
studies that investigate the association between parametrial 
invasion and other prognostic factors such as lymphatic 
invasion in peritumoral in cervical cancer. In addition, 
the relationship between parametrial invasion, VEGF-C 
expression, peritumoral lymph vessels with and LNM, and 
clinicopathological outcomes also have not been firmly 
established yet. The aim of the present study is to investigate 
the association of parametrial invasion with VEGF-C 
expression, LVI, LNM in cervical cancer stage IB-IIA.
Methods
This was a retrospective study. Tumor specimens were 
obtained from the Cipto Mangunkusumo Hospital, Jakarta 
and Hasan Sadikin Hospital, Bandung from September 
2014 to January 2016. The inclusion criteria were set as 
follows: cervical cancer stage IB-IIA according to the 1998 
Federation Internationale des Gynaecologistes et Obstetristes 
(FIGO) staging system and patients had undergone radical 
hysterectomy with lymph node dissection. Damaged and or 
insufficient amounts of paraffin blocks were excluded. The 
recent study was approved by the Research Ethic Committe 
of Faculty of Medicine, Universitas Indonesia (No. 564/
UN2.F1/ETIK/2014).
Histopathologic Examination
Histopathologic preparation was made with standard 
procedure. Initially, the tissues from specimens were fixed 
at 10% buffered formalin. The next sequential steps were 
paraffin-embedding and hematoxylin and eosin (H&E) 
staining. Evaluations of H&E slides of the cases were 
performed to confirm the diagnosis. The histopathologic 
features including histologic type, tumor staging and size, 
tumor differentiation, the presence of LVI, parametrium 
invasion, and LNM were assessed.
Immunohistochemistry 
Deparaffinization of the 4-µm-thick sections were performed 
in xylene, followed by rehydration in graded concentration 
of ethanol. The endogenous peroxidase activity within 
tissue was destructed by mixing with 3% H2O2 in phosphate 
buffer solution (PBS) for 20 minutes. Antigen retrieval was 
attained by immersing the sections in 0.01 M citrate buffer, 
pH 6.0 and heated in a decloaking chamber for 35 minutes. 
Nonspecific binding sites were blocked in phosphate-
buffered saline (PBS) for 20 minutes at room temperature. 
Primary antibodies for VEGF-C (1:150, Abcam, Cambridge, 
UK) was used and the slides were incubated overnight at 
4ºC. After rinsing twice with phosphate buffered saline 
(PBS) for 10 min, the sections were then incubated with 
a secondary solution Starr trek Universal HRP Detection 
system® (Biocare, Birmingham, UK) for 30 min at room 
temperature. Ultimately, the 3,3’-diaminobenzidine (DAB) 
was used according to the manufacturer’s instructions to 
visualize the peroxidase activity. Meyers hematoxylin 
was used to counterstain the sections. A positive staining 
was confirmed when brown color appeared. The sections 
were then cleaned using dH2O. The positive control was a 
single slide with squamous cell cervical carcinoma (SCCC) 
showed strong whose the sections were stained with VEGF 
antibody. The negative control was achieved by omitting the 
primary antibody.
 Cytoplasmic and membrane immunoreactivity in 
peritumor was evaluated semiquantitatively. The numbers 
of brown color stromal cell at peritumor area were evaluated 
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under light microscopic Olympus CX21 (Olympus, Tokyo 
Japan) and digital camera Optilab (Optilab, Phoenix, USA) 
at five random high power field. The expression of VEGF-C 
was defined as ‘low’ if there was no staining of inflammatory 
cells or staining of less than 5%, and defined as ‘high’ if the 
staining was more than 5%. The labeling was evaluated by 
two pathologists independently. If the results were not in 
agreement, they had to discuss to reach an agreement. 
Statistical Analysis
Numerical data were presented as mean ± standard deviation 
(SD) whereas categorical data as frequency. Comparison 
between two groups was analyzed using an independent 
sample of T-test. The association between LNM and 
VEGF-C expression with clinicopathology features, was 
analyzed using Chi-Square or Fisher’s exact test. The odds 
ratio (OR) and 95% confidence interval (CI) were also 
determined. A p-value of <0,05 was considered significant. 
Statistical analysis was computed by using the Statistical 
Package for the Social Sciences (SPSS) software version 17.
A total of seventy-five specimens were eligible. Table 1 
presented the clinicopathologic variables. Most of the cases 
were tumor in stage IB with size of ≤4 cm, well-moderate 
differentiated, and had well-moderate inflamation grade. 
Parametrial invasion and lymph nodes metastasis were 
found only in 15 (20%) and 18 (24%) patients, respectively. 
LVI was identified in half of the cases.  
 The VEGF-C showed heterogeneous immuno-
histochemical expression within the tumor. In peritumoral 
stroma VEGF-C showed moderate and strong staining 
intensity (Figure 1). VEGF-C expression in the peritumoral 
stroma was a predominant low expression (60 cases or 
80%), whereas only 15 (20%) cases showed high VEGF-C 
expression. In 15 cases with high VEGF-C expression, 
only 1 case showed the presence of LNM and no cases of 
parametrial invasion.
 Table 2 demonstrated the comparison between 
parametrial invasion and its association with the 
clinicopathological features. Age was not different between 
positive and negative parametrial invasion (p=0.65). 
Parametrial invasion had association with tumor size, LNM, 
and VEGF-C expression. The OR for tumor size, LNM, 
expression of VEGF-C were 4.32 (95% CI 1.29-14.38, 
p=0.01), 3.90 (95% CI 1.17-13.03, p=0.02), 0.75 (95% CI 
0.65-0.87, p=0.03). 
Results
46.2±7.9
Stage
FIGO IB1-IB2 53 70.70%
FIGO IIA1-IIA2 22 29.30%
Tumour size
≤ 4 cm 46 61.30%
> 4 cm 29 38.70%
Differentiation grade
Well-moderate 58 77.30%
Poor 17 22.70%
Inflammation grade 
Mild-moderate 43 57.30%
Severe 32 42.70%
Lymphatic vascular invasion
Negative 37 49.30%
Positive 38 50.70%
Parametrial invasion
Negative 60 80.00%
Positive 15 20.00%
Lymph node metastasis
Negative 57 76.00%
Positive 18 24.00%
Frequency (%)
Age (years, mean±SD)                                
Clinicohistopathology 
Variables
Table 1.Clinicohystopathology variables.
 The association between VEGF-C expression and 
clinicopathology variables was shown in Table 3. The 
results show there was no association between age, stage, 
tumor size, histological grade, degree of inflammation 
and LVI with VEGF-C expression. The same results were 
demonstrated with LNM variable, there was a tendency of 
decreased expression of VEGF-C in peritumoral cervical 
SCC with LNM compared without LNM (p=0.09). A 
tendency between low expression of VEGF-C and LNM 
was noted, however, the association was not statistically 
significantly (p=0.10). The expression of VEGF-C is only 
related with parametrial invasion (in Table 2, p=0.03). There 
was no relationship between VEGF-C expression and other 
clinicohystopathology factors. 
Discussion
Parametrial invasion indicates a poor prognosis and 
has implications for the need for more radical surgery. 
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Figure 1. Expression of VEGF-C in peritumoral stroma cervical SCCC. A: low expression, less than 5% inflammatory cells positive 
VEGF-C (arrow); B: high expression, more than 5% inflammatory cells positive VEGF-C (arrow). T: tumor, S: stroma; white bar: 10 mm.
Table 2. The association between clinicopathology characteristics and parametrial invasion.
Positif Negative
Age (years) 45.5±7.8 46.5±8.0 0.65
Stage
FIGO IB1-IB2 11 42
FIGO IIA1-IIA2 4 18
Tumour size (cm)
≤ 4 cm 5 41
> 4 cm 10 19
Differentiation grade
Well-moderate 11 47
Poor 4 13
Inflammation grade 
Mild-moderate 2 13
Severe 13 47
Lymphatic vascular invasion
Negative 5 32
Positive 10 28
Lymph node metastasis
Negative 8 49
Positive 7 11
VEGF-C expression
Low 15 45
High 0 15
0.17 2.29 (0.70-7.49)
0.02 3.90 (1.17-13.03)
0.03 0.75 (0.65-0.87)
0.01 4.32 (1.29-14.38)
0.73 1.32 (0.36-4.82)
0.72 1.80 (0.36-9.00)
Parametrial Invasion 
p- value OR (95%CI)Clinicopathological Characteristics
0.99 0.85 (0.24-3.02)
Parametrial tissue resection during radical hysterectomy, 
however may cause partial denervation of the autonomic 
nerve resulting in postoperative complications. The factors 
related to parametrial invasion in the early stage of SCCC 
should be identified for determining the risk of parametrial 
involvement. Our study found parametrial invasion occurred 
in 20% (15 cases).  Parametrial invasion was related to tumor 
size of >4 cm, LNM,  and low expression of VEGF-C but 
not  with  other  variables.  Tumor  size  >4 cm,  LNM,  and 
high expression of VEGF-C had OR 4.32, 3.90 and 0.75, 
respectively. However, the association with VEGF-C was 
reversed  and  did  not  match  with  what  was  expected. 
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Low (n=60) High (15)
Stage
FIGO IB1-IB2 45 8
FIGO IIA1-IIA2 15 7
Tumour size (cm)
≤ 4 cm 36 10
> 4 cm 24 5
Histological grade  
Well differentiated 46 12
Moderate-poorly differentiated 14 3
Lymphatic vascular invasion
Negative 31 6
Positive 29 9
Lymph node metastasis
Negative 43 14
Positive 17 1
 
0.42
0.09
Clinicopathologic variables
VEGF-C expression
p- value
0.12
0.64
1
Table 3. The association between VEGF-C expression and clinicohystopathology 
variables.
In addition, VEGF-C has no association significantly with 
any variables.
 Parametrium is the most frequent site of local spread of 
cervical cancer and its metastatic spread mainly lymphatic.
(16) The tumor dissemination to parametrial tissue need 
resection, which is a more radical surgery causing known 
complications such as dysfunction of the bladder, erectile 
organ, and anorectal peristalsis.(17) Infertility is the most 
concerning complication for reproductive women who 
undergone radical surgery.(16) Previous studies have 
been performed to identify the risk factors for parametrial 
metastasis. This can help identify patients with low risk 
of parametrial metastasis and perform less radical surgery. 
Study on cervical carcinoma reported that patients with 
stage IB1 accompanied by superficial invasion (<5 mm) 
were at very low risk of parametrial invasion. Some previous 
studies demonstrate that parametrial invasion are related to 
tumor size, histologic grade, LNM, and LVI. The incidence 
of parametrial involvement is negative or low in primary 
tumor size of less than 2 cm, no LVI, no LNM.(18-21) In 
agreement with some previous studies, this study reported 
any association between parametrial invasion with tumor 
size, LNM, and VEGF-C expression.  
 The association between parametrial invasion and 
VEGF-C expression was not evident in this study. With a 
significant p-value, the association was not as expected, in 
which parametrial invasion was more pronounced in low 
expression rather than in high expression of VEGF-C. The 
mechanism is not clearly understood, but it might be related 
to tumor cells invasion. Spreading tumor cells into lymphatic 
vessels could destroy the lymphatic endothelial lead to low 
expression of VEGF-C. However, this finding needs further 
evaluation to confirm whether VEGF-C indeed associate 
with parametrial invasion. 
 VEGF-C specifically acts on lymphatic endothelial 
cells through its recepto, VEGFR-3 to form new lymphatic 
vessels.(22,23) Study in cervical carcinoma indicated 
that VEGFR-3 expression was increased and correlated 
significantly with peritumoral LVD.(23) A similar results 
was reported which also found an increased VEGV-C 
expression was in accordance with clinical stage in SCCC.
(11) Our study was not in agreement with those previous 
studies. The expression of VEGF-C had no association 
with LVI. We did not have not some definite explanation, 
but it might be related to histologic staining methods. With 
histologic appearance that resembles blood vessel, lymphatic 
vessel invasion could not be distinguished by the H&E 
staining method.(24) To date, some more specific staining 
method (for example: D2-40, a monoclonal antibody) has 
been considered to have better capability to distinguish the 
vessels because it selectively stain lymphatic endothelial 
and exclusively found in the peritumoral area.(23,25-27) 
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 Both intra- or peritumoral lymphatic have a role 
on tumor cells dissemination and clinicopathology but 
the results vary between studies. It has been reported 
that peritumoral lymphatic vessels could be a potential 
prognostic marker for endometrial carcinoma.(28) A meta-
analysis study reported that peritumoral lymphatic vessels 
was thought to be the main dissemination route in breast 
cancer.(29) On the other hand, a previous study found a 
conflicting result in which intratumoral LVD had a strong 
association with LNM and prognosis.(15) However, a more 
recent study reported that both intratumoral and peritumoral 
LVD correlate with LNM.(30) We examined peritumoral 
lymphatic as it was considered to be more often associated 
with nodal metastasis and clinicopathological features. In 
addition, intratumoral lymphatic is sometimes collapse 
because it has been invaded and destroyed by tumor cells.
(31,32) Our study did not find any correlations between LVI 
with LNM and VEGF-C. LVI has been regarded as a strong 
prognostic factor in breast cancer.(33,34) Yet, previous 
study evaluating the relationship between LVD, LVI, and 
LNM demonstrated that LVD correlated moderately and 
LVI correlated weakly with LNM.(29)
 Not every tumor types demonstrates the association 
of VEGF-C with LNM. Research during recent years has 
provided more understanding towards the mechanism 
of local invasion and lymphatic spread. Nowadays, two 
lymphangiogenic growth factors, VEGF-C and VEGF-D, 
are recognized. They are produced by both tumor and 
stromal cells. These growth factors induce proliferation and 
migration of cancer cells through signaling via VEGFR-3 
receptor found in lymphatic endothelial cells.(23) Secreted 
in an active form, VEGF-C and VEGF-D have an ability 
to bind VEGFR-3. The VEGF-C and VEGF-D will be 
processed by protease into an active form with higher 
affinity for VEGFR-3 in the extracellular environment.
(21,24) There was an indication of overlapping functions 
between these two growth factors, because a deficiency of 
VEGF-C can be replaced by VEGF-D.(24) Similar evidence 
was shown in colorectal cancer with decreased VEGF-D, 
in which the carcinoma may enhance the elevated levels 
of VEGF-C to bind with VEGFR-3 easily. The balance of 
different VEGF family members changes significantly, in 
which the ratio of VEGF-C and VEGF-D is essential for 
lymphatic invasion and metastasis.(22) 
 Limitations of this study have been documented. First, 
we did not examine LVD as an indicator for lymphatic 
invasion. Second, we did not use D2-40 staining even though 
it is a more specific staining for endothelial lymphatic 
vessels. The use of D2-40 could improve detection rates and 
avoid the false positive or negative as well. Third, VEGF-D 
expression was not examined. The VEFG-D, like VEGF-C, 
is also a potential regulator for lymphangiogenesis. The 
presence of VEGF-D expression is needed to confirm the 
lymphatic vascular invasion which could not be detected by 
VEGF-C.
Conclusion
In conclusion, this study indicates that parametrial invasion 
has association with tumor size and LNM, but not with 
VEGF-C expression. Tumor size of >4 cm and positive 
LNM in stage IB-IIA squamous cell carcinoma increased the 
risk of parametrial invasion. Even with a significant result, 
the association of parametrial invasion and the VEGF-C is 
not conclusive because the direction of association is not 
appropriate. A further investigation is needed to confirm the 
association.
1.  Horton R. GBD 2010: understanding disease, injury, and risk. Lancet. 
2012; 380: 2053-4
2. Viens LJ, Henley SJ, Watson M, Markowitz LE, Thomas CC, 
Thompson TD, et al. Human papillomavirus–associated cancers—
United States, 2008–2012. MMWR Morb Mortal Wkly Rep. 2016; 
65: 661-6.
3. Chen Z, Huang K, Lu Z, Deng S, Xiong J, Huang J, et al. Risk model 
in stage IB1-IIB cervical cancer with positive node after radical 
hysterectomy. Onco Targets Ther. 2016; 9: 3171-9.
4. Wright JD, Grigsby PW, Brooks R, Powell MA, Gibb RK, Gao F, et 
al. Utility of parametrectomy for early stage cervical cancer treated 
with radical hysterectomy. Cancer. 2007; 110: 1281-6.
5. Kitadai Y, Amioka T, Haruma K, Tanaka S, Yoshihara M, Sumii K, et 
al. Clinicopathological significance of vascular endothelial growth 
factor (VEGF)-C in human esophageal squamous cell carcinomas. 
Int J Cancer. 2001; 93: 662-6.
6. Hadler-Olsen E, Wetting HL, Rikardsen O, Steigen SE, 
Kanapathippillai P, Grénman R, et al. Stromal impact on tumor 
growth and lymphangiogenesis in human carcinoma xenografts. 
Virchow Arch. 2010; 457: 677-92.
7. He Y, Rajantie I, Pajusola K, , Jeltsch M, Holopainen T, Yla-Herttuala 
S, et al. Vascular endothelial cell growth factor receptor 3-mediated 
activation of lymphatic endothelium is crucial fortumor cells entry 
and spread via lymphatic vessels. Cancer Res. 2005; 65: 4739-46.    
8. Lohela M, Bry M, Tammela T, Alitalo K. VEGFs and receptors 
involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell 
Biol. 2009; 21: 154-65. 
Acknowledgements
Authors would like to thanks laboratory staffs for technical 
support, and medical record officers for providing data.
References
285
 Parametrial Invasion in Cervical Carcinoma (Lilis, et al.)Indones Biomed J. 2019; 11(3): 279-85DOI: 10.18585/inabj.v11i3.838
9. Zhang Z, Luo G, Tang H, Cheng C, Wang P. Prognostic significance 
of high VEGF-C expression for patients with breast cancer: An 
update meta analysis. PLoSONE. 2016: 11: e0165725. doi: 10.1371/
journal.pone.0165725.
10. Liu P, Chen W, Zhu H, Liu B, Song S, Shen W, et al. Expression 
of VEGF-C correlates with a poor prognosis based on analysis of 
prognostic factors in 73 patients with esophageal squamous cell 
carcinomas. Jpn J Clin Oncol. 2009; 39: 644-50.
11. Franc M, Kachel-Flis A, Michalski B, Fila-Daniłow A, Mazurek U, 
Michalski M, et al. Lymphangiogenesis in cervical cancer evaluated 
by expression of the VEGF-C gene in clinical stage IB-IIIB. Prz 
Menopauzalmy. 2015; 14: 112-7. 
12. Lee K, Park DJ, Choe G, Kim HH, Kim WH, Lee HS. Increased 
intratumoral lymphatic vessel density correlates with lymph node 
metastasis in early gastric carcinoma. Ann Surg Oncol. 2010; 17: 
73-80.
13. Gao P, Zhou GY, Zhang QH, Xiang L, Zhang SL, Li C, et al. 
Clinicopathological significance of peritumoral lymphatic vessel 
density in gastric carcinoma. Cancer Lett. 2008; 263: 223-30.
14. Gombos Z, Xu X, Chu CS, Zhang PJ, Acs G. Peritumoral lymphatic 
vessel density and vascular endothelial growth factor-c expression 
in early-stage squamous cell carcinoma of the uterine cervix. Clin 
Cancer Res. 2005; 11: 8364-71.
15. Donizy P, Rudno-Rudzinska J, Halon A, Dziegala M, Kabarowski J, 
Frejlich E, et al. Intratumoral but not peritumoral Lymphatic Vessel 
Density measured by D2-40 expression predicts poor outcome in 
gastric cancer – ROC curve analysis to find cut-off point. Anticancer 
Research. 2014; 34: 3113-8.
16. Stegeman M, Louwen M, van der Velden J, ten Kate FJW, den 
Bakker MA, Burger CW, et al. The incidence of parametrial tumor 
involvement in select patients with early cervix cancer is too low to 
justify parametrectomy. Gynecol Oncol. 2007: 105; 475-80.
17. Lee SH, Cho KJ, Ko MH, Cho HY, Lee KB, Lim S. Factors associated 
with parametrial involvement in patients with stage IB1 cervical 
cancer: Who is suitable for less radical surgery? Obstet Gynecol 
Sci. 2018; 61: 88-94.
18. Kim MK, Kim JW, Kim MA, Kim HS, Chung HH, Park NH, et 
al. Feasibility of less radical surgery for superficially invasive 
carcinoma of the cervix. Gynecol Oncol. 2010; 119: 187-191.
19. Frumovitz M, Sun CC, Schmeler KM, Deavers MT, dos Reis 
R, Levenback CF, et al. Parametrial involvement in radical 
hysterectomy specimens for women with early-stage cervical 
cancer. Obstet Gynecol. 2009; 114: 93-9.
20. Kamimori T, Sakamoto K, Fujiwara K, Umayahara K, Sugiyama Y, 
Utsugi K, et al. Parametrial involvement in FIGO stage IB1 cervical 
carcinoma diagnostic impact of tumor diameter in preoperative 
magnetic resonance imaging. Int J Gynecol Cancer. 2011; 21: 349-
54.
21. Smith AL, Frumovitz M, Schmeler KM, dos Reis R, Nick AM, 
Coleman RL, et al. Conservative surgery in early-stage cervical 
cancer: what percentage of patients may be eligible for conization 
and lymphadenectomy? Gynecol Oncol. 2010; 119: 183-6.
22. Saharinen I, Tammela T, Karkkainen M, Alitalo K. Lymphatic 
vasculature: development, molecular regulation, and role in tumor 
metastasis and inflammation. Trends Immunol. 2004; 25: 387-95.
23. Botting SK, Fouad H, Elwell K, Rampy BA, Salama SA, Freeman 
DH, et al. Prognostic significance of peritumoral lymphatic vessel 
density and vascular endothelial growth factor receptor 3 in invasive 
squamous cell cervical cancer. Translational Oncology. 2010; 3: 
170-5.
24. El-Gohary YM, Metwally G, Saad RS, Robinson MJ, Mesko T, 
Poppiti RJ. Prognostic significance of intratumoral and peritumoral 
lymphatic density and blood vessel density in invasive breast 
carcinomas. Am J Clin Pathol. 2008; 129: 578-86.
25. Wang XL, Fang JP, Tang RY, Chen XM. Different significance 
between intratumoral and peritumoral lymphatic vessel density in 
gastric cancer: a retrospective study of 123 cases. BMC Cancer. 
2010; 10: 299.  doi: 10.1186/1471-2407-10-299.
26. Schoppmann SF, Birner P, Studer P, Breiteneder-Geleff S. Lymphatic 
microvessel density and lymphovascular invasion assessed by anti-
podoplanin immunostaining in human breast cancer. Anticancer 
Res. 2001; 21: 2351-5.
27. Urabe A, Matsumoto T, Kimura M, Sonoue H, Kinoshita K. Grading 
system of lymphatic invasion according to D2-40 immunostaining 
is useful for the prediction of nodal metastasis in squamous cell 
carcinoma  of  the  uterine  cervix.  Hystopathology.  2006;  49: 
493-7.
28. Gao Y, Liu Z, Gao F, Meng XY. High density of peritumoral lymphatic 
vessels is a potential prognostic marker of endometrial carcinoma: 
a clinical immunohistochemical method study. BMC Cancer. 2010; 
10: 131. doi: 10.1186/1471-2407-10-131.  
29. Zhang S, Zhang D, Yi S, Gong M, Lu C, Cai Y, et al. The relationship 
of lympatic vessel density, lymphovascular invasion, and lymph 
node metastasis in breast cancer: a systematic review and meta-
analysis. Oncotarget. 2017; 8: 2863-73.
30. Zhang S, Yi S, Zhang D, Gong M, Cai Y, Zou L. Intratumoral and 
peritumoral lymphatic vessel density both correlate with lymph node 
metastasis in breast cancer. Sci Rep. 2017; 7: 40364. doi:10.1038/
srep40364.
31. Ji RC. Lymphatic endothelial cells, tumor lymphangiogenesis, 
and metastasis: new insight into intratumoral and peritumoral 
lymphatics. Cancer Metastasis Rev. 2006; 25: 677-94.  
32. Leu AJ, Berk DA, Lymboussaki A, Alitalo K, Jain RK. Absence of 
functional lymphatics within a murine sarcoma: a molecular and 
functional evaluation. Cancer Res. 2000; 60: 4324-7.
33. He KW, Sun JJ, Liu ZB, Zhuo PY, Ma QH, Liu ZY, et al. Prognostic 
significance of lymphatic vessel invasion diagnosed by D2-40 in 
Chinese invasive breast cancers. Medicine (Baltimore). 2017; 96: 
e8490. doi: 10.1097/MD.0000000000008490.
34. Norhisham NF, Chong CY, Safuan S. Peritumoral lymphatic vessel 
density and invasion detected with immunohistochemical marker 
D240 is strongly associated with distant metastasis in breast 
carcinoma. BMC Clin Pathol. 2017; 17: 2. doi: 10.1186/s12907-
017-0041-4.
